Guided Therapeutics (GTHP) Assets Average (2012 - 2026)

Guided Therapeutics has disclosed Assets Average across 15 years of filings, most recently posting $1.4 million for Q2 2026.

• In Q2 2026, Assets Average rose 46.78% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (up 46.78% YoY), while the FY2025 annual figure was $1.4 million, down 11.32% from the prior year.
• Assets Average came in at $1.4 million for Q2 2026 at Guided Therapeutics, down from $1.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $3.6 million in Q4 2022 to a low of $921500.0 in Q3 2025.
• Average Assets Average over 5 years is $1.8 million, with a median of $1.5 million recorded in 2024.
• Year-over-year, Assets Average surged 91.25% in 2022 and tumbled 51.0% in 2023.
• Over 5 years, Assets Average stood at $3.6 million in 2022, then plunged by 51.0% to $1.8 million in 2023, then retreated by 25.92% to $1.3 million in 2024, then dropped by 15.23% to $1.1 million in 2025, then gained by 25.68% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $1.4 million in Q2 2026, $1.5 million in Q1 2026, and $1.1 million in Q4 2025.